Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

14.90
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
10.25
Today|||52-Week Range
24.25
-5.70%
Year-to-Date
No recent news for Melinta Therapeutics, Inc..

Today’s Trading

Previous close14.90
Today’s open14.65
Day’s range14.30 - 15.00
Volume104,966
Average volume (3 months)165,034
Market cap$466.7M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-11.96%
Earnings growth (this year)+60.85%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.03%
P/E ratioNM
Price/Sales7.82
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...0.000.00%
CDMOAvid Bioservices Inc0.000.00%
RDHLRedhill Biopharma Lt...0.000.00%
TRVNTrevena Inc0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$18.0M
Annual profit (last year)-$118.0M
Net profit margin-654.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
Chief Financial Officer, Secretary &
EVP
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts